Celiac disease screening in children and adolescents with type1 diabetes mellitus: What test should be performed?

Children and adolescents with type1 diabetes mellitus (T1DM) are at high risk for the development of celiac disease (CD) because of the common genetic characteristics of both conditions. The study objectives were to investigate the frequency of the human leukocyte antigen system (HLA) for CD in pedi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrinologia, diabetes y nutricion diabetes y nutricion, 2021-03, Vol.68 (3), p.153-158
Hauptverfasser: Roldán Martín, M Belén, Márquez Romero, Corina, Guerra Vilches, Enrique, Ruiz Usabiaga, Juan, Barrio Castellanos, Raquel, Martín Frías, María, Plaza Oliver, David, Camarero Salces, Cristina
Format: Artikel
Sprache:eng ; spa
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 158
container_issue 3
container_start_page 153
container_title Endocrinologia, diabetes y nutricion
container_volume 68
creator Roldán Martín, M Belén
Márquez Romero, Corina
Guerra Vilches, Enrique
Ruiz Usabiaga, Juan
Barrio Castellanos, Raquel
Martín Frías, María
Plaza Oliver, David
Camarero Salces, Cristina
description Children and adolescents with type1 diabetes mellitus (T1DM) are at high risk for the development of celiac disease (CD) because of the common genetic characteristics of both conditions. The study objectives were to investigate the frequency of the human leukocyte antigen system (HLA) for CD in pediatric T1DM patients and to determine whether HLA testing is suitable for CD screening in that population and is cost-effective as compared to serological screening for CD. A retrospective, descriptive study was conducted in 296 patients (148 girls; 148 boys) with T1DM aged
doi_str_mv 10.1016/j.endinu.2020.03.007
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2420152317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2420152317</sourcerecordid><originalsourceid>FETCH-LOGICAL-p568-14255e4f9479526ca459c0700f718a9bad207ea4714898168df2e2c6693894793</originalsourceid><addsrcrecordid>eNo1kE1Lw0AYhBdBbKn9ByJ79NL47lc28SJS_IKCl4LHsMm-MVs2mzSbIP33RqyngWFmeBhCbhgkDFh6f0gwWBemhAOHBEQCoC_IkisBG2CaL8g6xgMAcCGV5uyKLARPOSiWLclxi96ZiloX0USksRoQgwtf1AVaNc7bAQM1wVJjO4-xwjBG-u3Gho6nHtlcNCWOGGmL3rtxig_0szEjna2RxqabvKUl0h6HuhtatI_X5LI2PuL6rCuyf3neb982u4_X9-3TbtOrNNswyZVCWedS54qnlZEqr0AD1JplJi-N5aDRSM1klmcszWzNkVdpmovstyNW5O5vth-64zTDFK2b6b03AbspFlxyYIoLpufo7Tk6lTNh0Q-uNcOp-H9J_AC2sGmt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2420152317</pqid></control><display><type>article</type><title>Celiac disease screening in children and adolescents with type1 diabetes mellitus: What test should be performed?</title><source>Alma/SFX Local Collection</source><creator>Roldán Martín, M Belén ; Márquez Romero, Corina ; Guerra Vilches, Enrique ; Ruiz Usabiaga, Juan ; Barrio Castellanos, Raquel ; Martín Frías, María ; Plaza Oliver, David ; Camarero Salces, Cristina</creator><creatorcontrib>Roldán Martín, M Belén ; Márquez Romero, Corina ; Guerra Vilches, Enrique ; Ruiz Usabiaga, Juan ; Barrio Castellanos, Raquel ; Martín Frías, María ; Plaza Oliver, David ; Camarero Salces, Cristina</creatorcontrib><description>Children and adolescents with type1 diabetes mellitus (T1DM) are at high risk for the development of celiac disease (CD) because of the common genetic characteristics of both conditions. The study objectives were to investigate the frequency of the human leukocyte antigen system (HLA) for CD in pediatric T1DM patients and to determine whether HLA testing is suitable for CD screening in that population and is cost-effective as compared to serological screening for CD. A retrospective, descriptive study was conducted in 296 patients (148 girls; 148 boys) with T1DM aged &lt;18years who attended a hospital in Madrid. Data on the frequency of genotypes DQ2/DQ8 in a subgroup of 92 patients and the additional cost of performing HLA typing for screening CD were collected. Only when the risk HLA haplotype (DQ2/DQ8) is negative no further serological screening for CD is required. Twenty-three patients with T1DM (7.77%) also had CD. Alleles DQ2 or DQ8 were found in 91.3% of patients in whom the HLA haplotype was studied. Thus, only 8.7% with a negative haplotype would have benefited from HLA testing. The additional cost of HLA typing was €105.2 for each patient with positive DQ2 or DQ8 in our population. HLA typing is not a cost-effective screening method for CD in T1DM because of the frequent association of T1DM with risk genotypes for CD.</description><identifier>EISSN: 2530-0172</identifier><identifier>EISSN: 2530-0180</identifier><identifier>DOI: 10.1016/j.endinu.2020.03.007</identifier><identifier>PMID: 32620518</identifier><language>eng ; spa</language><publisher>Spain</publisher><ispartof>Endocrinologia, diabetes y nutricion, 2021-03, Vol.68 (3), p.153-158</ispartof><rights>Copyright © 2020 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32620518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roldán Martín, M Belén</creatorcontrib><creatorcontrib>Márquez Romero, Corina</creatorcontrib><creatorcontrib>Guerra Vilches, Enrique</creatorcontrib><creatorcontrib>Ruiz Usabiaga, Juan</creatorcontrib><creatorcontrib>Barrio Castellanos, Raquel</creatorcontrib><creatorcontrib>Martín Frías, María</creatorcontrib><creatorcontrib>Plaza Oliver, David</creatorcontrib><creatorcontrib>Camarero Salces, Cristina</creatorcontrib><title>Celiac disease screening in children and adolescents with type1 diabetes mellitus: What test should be performed?</title><title>Endocrinologia, diabetes y nutricion</title><addtitle>Endocrinol Diabetes Nutr</addtitle><description>Children and adolescents with type1 diabetes mellitus (T1DM) are at high risk for the development of celiac disease (CD) because of the common genetic characteristics of both conditions. The study objectives were to investigate the frequency of the human leukocyte antigen system (HLA) for CD in pediatric T1DM patients and to determine whether HLA testing is suitable for CD screening in that population and is cost-effective as compared to serological screening for CD. A retrospective, descriptive study was conducted in 296 patients (148 girls; 148 boys) with T1DM aged &lt;18years who attended a hospital in Madrid. Data on the frequency of genotypes DQ2/DQ8 in a subgroup of 92 patients and the additional cost of performing HLA typing for screening CD were collected. Only when the risk HLA haplotype (DQ2/DQ8) is negative no further serological screening for CD is required. Twenty-three patients with T1DM (7.77%) also had CD. Alleles DQ2 or DQ8 were found in 91.3% of patients in whom the HLA haplotype was studied. Thus, only 8.7% with a negative haplotype would have benefited from HLA testing. The additional cost of HLA typing was €105.2 for each patient with positive DQ2 or DQ8 in our population. HLA typing is not a cost-effective screening method for CD in T1DM because of the frequent association of T1DM with risk genotypes for CD.</description><issn>2530-0172</issn><issn>2530-0180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo1kE1Lw0AYhBdBbKn9ByJ79NL47lc28SJS_IKCl4LHsMm-MVs2mzSbIP33RqyngWFmeBhCbhgkDFh6f0gwWBemhAOHBEQCoC_IkisBG2CaL8g6xgMAcCGV5uyKLARPOSiWLclxi96ZiloX0USksRoQgwtf1AVaNc7bAQM1wVJjO4-xwjBG-u3Gho6nHtlcNCWOGGmL3rtxig_0szEjna2RxqabvKUl0h6HuhtatI_X5LI2PuL6rCuyf3neb982u4_X9-3TbtOrNNswyZVCWedS54qnlZEqr0AD1JplJi-N5aDRSM1klmcszWzNkVdpmovstyNW5O5vth-64zTDFK2b6b03AbspFlxyYIoLpufo7Tk6lTNh0Q-uNcOp-H9J_AC2sGmt</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Roldán Martín, M Belén</creator><creator>Márquez Romero, Corina</creator><creator>Guerra Vilches, Enrique</creator><creator>Ruiz Usabiaga, Juan</creator><creator>Barrio Castellanos, Raquel</creator><creator>Martín Frías, María</creator><creator>Plaza Oliver, David</creator><creator>Camarero Salces, Cristina</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202103</creationdate><title>Celiac disease screening in children and adolescents with type1 diabetes mellitus: What test should be performed?</title><author>Roldán Martín, M Belén ; Márquez Romero, Corina ; Guerra Vilches, Enrique ; Ruiz Usabiaga, Juan ; Barrio Castellanos, Raquel ; Martín Frías, María ; Plaza Oliver, David ; Camarero Salces, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p568-14255e4f9479526ca459c0700f718a9bad207ea4714898168df2e2c6693894793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roldán Martín, M Belén</creatorcontrib><creatorcontrib>Márquez Romero, Corina</creatorcontrib><creatorcontrib>Guerra Vilches, Enrique</creatorcontrib><creatorcontrib>Ruiz Usabiaga, Juan</creatorcontrib><creatorcontrib>Barrio Castellanos, Raquel</creatorcontrib><creatorcontrib>Martín Frías, María</creatorcontrib><creatorcontrib>Plaza Oliver, David</creatorcontrib><creatorcontrib>Camarero Salces, Cristina</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrinologia, diabetes y nutricion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roldán Martín, M Belén</au><au>Márquez Romero, Corina</au><au>Guerra Vilches, Enrique</au><au>Ruiz Usabiaga, Juan</au><au>Barrio Castellanos, Raquel</au><au>Martín Frías, María</au><au>Plaza Oliver, David</au><au>Camarero Salces, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Celiac disease screening in children and adolescents with type1 diabetes mellitus: What test should be performed?</atitle><jtitle>Endocrinologia, diabetes y nutricion</jtitle><addtitle>Endocrinol Diabetes Nutr</addtitle><date>2021-03</date><risdate>2021</risdate><volume>68</volume><issue>3</issue><spage>153</spage><epage>158</epage><pages>153-158</pages><eissn>2530-0172</eissn><eissn>2530-0180</eissn><abstract>Children and adolescents with type1 diabetes mellitus (T1DM) are at high risk for the development of celiac disease (CD) because of the common genetic characteristics of both conditions. The study objectives were to investigate the frequency of the human leukocyte antigen system (HLA) for CD in pediatric T1DM patients and to determine whether HLA testing is suitable for CD screening in that population and is cost-effective as compared to serological screening for CD. A retrospective, descriptive study was conducted in 296 patients (148 girls; 148 boys) with T1DM aged &lt;18years who attended a hospital in Madrid. Data on the frequency of genotypes DQ2/DQ8 in a subgroup of 92 patients and the additional cost of performing HLA typing for screening CD were collected. Only when the risk HLA haplotype (DQ2/DQ8) is negative no further serological screening for CD is required. Twenty-three patients with T1DM (7.77%) also had CD. Alleles DQ2 or DQ8 were found in 91.3% of patients in whom the HLA haplotype was studied. Thus, only 8.7% with a negative haplotype would have benefited from HLA testing. The additional cost of HLA typing was €105.2 for each patient with positive DQ2 or DQ8 in our population. HLA typing is not a cost-effective screening method for CD in T1DM because of the frequent association of T1DM with risk genotypes for CD.</abstract><cop>Spain</cop><pmid>32620518</pmid><doi>10.1016/j.endinu.2020.03.007</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier EISSN: 2530-0172
ispartof Endocrinologia, diabetes y nutricion, 2021-03, Vol.68 (3), p.153-158
issn 2530-0172
2530-0180
language eng ; spa
recordid cdi_proquest_miscellaneous_2420152317
source Alma/SFX Local Collection
title Celiac disease screening in children and adolescents with type1 diabetes mellitus: What test should be performed?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T07%3A37%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Celiac%20disease%20screening%20in%20children%20and%20adolescents%20with%20type1%20diabetes%20mellitus:%20What%20test%20should%20be%20performed?&rft.jtitle=Endocrinologia,%20diabetes%20y%20nutricion&rft.au=Rold%C3%A1n%20Mart%C3%ADn,%20M%20Bel%C3%A9n&rft.date=2021-03&rft.volume=68&rft.issue=3&rft.spage=153&rft.epage=158&rft.pages=153-158&rft.eissn=2530-0172&rft_id=info:doi/10.1016/j.endinu.2020.03.007&rft_dat=%3Cproquest_pubme%3E2420152317%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2420152317&rft_id=info:pmid/32620518&rfr_iscdi=true